Plain-English translation of NCT06855706 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether a personalized exercise program, supported by a wearable fitness tracker (Fitbit), helps women with ovarian, endometrial, or related cancers reach and maintain a goal of 150 minutes of moderate-to-vigorous activity per week. Some participants will receive personalized exercise goals and ongoing coaching, while others will receive standard exercise recommendations. The study aims to see if the personalized approach helps people exercise more, feel better, and may even support their immune system.
Exercise can help cancer patients recover, manage side effects, and improve quality of life, but many patients struggle to stay active during and after cancer treatment. This study wants to learn whether personalized coaching and real-time feedback from a wearable device can help patients overcome these barriers and stick with an exercise routine.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to either a personalized exercise program or a standard exercise program for 6 months. If you are in the personalized group, you will receive customized exercise goals that increase gradually, positive feedback, and ongoing support to help you reach 150 minutes of activity per week. Both groups will wear a Fitbit and a continuous glucose monitor throughout the study, complete questionnaires about quality of life and activities, and provide blood samples at various points. You will need to visit Roswell Park regularly for your cancer care and study check-ins.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United States